Key Insights Innospec's estimated fair value is US$76.00 based on 2 Stage Free Cash Flow to Equity Current share ...
NeuPath Health Inc. (TSXV:NPTH) (NeuPath or the "Company") today announced the timing and details for a planned leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results